NCT07407959 Screening and Staging of Benign vs Malignant Pelvic Abnormalities
| NCT ID | NCT07407959 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Endometrial Carcinoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-09-04 |
| Primary Completion | 2028-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60 participants in total. It began in 2025-09-04 with a primary completion date of 2028-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study evaluates whether newly developed non-FDA approved image processing techniques \[Adaptive Image Reconstruction (AIR Recon) Deep Learning (DL) and Sonic DL\] can provide improved quality and decreased time compared to current scanning techniques.
Eligibility Criteria
Inclusion Criteria: * Patient over the age of 18 * For prostate group, any patient referred for prostate MR for screening purposes with no prior prostate related treatment or prior biopsy * For endometriosis group, any patient referred for possible endometriosis evaluation (pre-surgical) Exclusion Criteria: * Individuals unable to undergo MRI imaging (MR-conditional or MR-nonconditional devices which would need additional procedures/conditions for scanning, pregnant people, individuals with implanted metal, etc.) * Patient under the age of 18 * Patient who is unable to consent
Contact & Investigator
Candice A. Bookwalter, MD, PhD
PRINCIPAL INVESTIGATOR
Mayo Clinic in Rochester
Frequently Asked Questions
Who can join the NCT07407959 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Endometrial Carcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07407959 currently recruiting?
Yes, NCT07407959 is actively recruiting participants. Contact the research team at mayocliniccancerstudies@mayo.edu for enrollment information.
Where is the NCT07407959 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT07407959 clinical trial?
NCT07407959 is sponsored by Mayo Clinic. The principal investigator is Candice A. Bookwalter, MD, PhD at Mayo Clinic in Rochester. The trial plans to enroll 60 participants.